PortfoliosLab logoPortfoliosLab logo
TBLA vs. GMED
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

TBLA vs. GMED - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Taboola.com Ltd. (TBLA) and Globus Medical, Inc. (GMED). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, TBLA achieves a 19.74% return, which is significantly higher than GMED's -10.54% return.


TBLA

1D
-1.08%
1M
16.70%
6M
29.58%
YTD
19.74%
1Y
52.07%
3Y*
19.31%
5Y*
-10.97%
10Y*

GMED

1D
1.92%
1M
-2.99%
6M
-17.32%
YTD
-10.54%
1Y
36.75%
3Y*
8.91%
5Y*
-0.63%
10Y*
12.07%
*Multi-year figures are annualized to reflect compound growth (CAGR)

TBLA vs. GMED - Yearly Performance Comparison


2026 (YTD)20252024202320222021
TBLA
Taboola.com Ltd.
19.74%26.30%-15.70%40.58%-60.41%-29.53%
GMED
Globus Medical, Inc.
-10.54%5.56%55.21%-28.25%2.87%-5.45%

Correlation

The correlation between TBLA and GMED is 0.01, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.01

Correlation (3Y)
Calculated over the trailing 3-year period

0.17

Correlation (5Y)
Calculated over the trailing 5-year period

0.24

Correlation (All Time)
Calculated using the full available price history since Jun 30, 2021

0.23

Over the past year, the correlation between TBLA and GMED has dropped to 0.01 - well below their long-term average of 0.23, suggesting their price drivers have been diverging.

Fundamentals

Market Cap

TBLA:

$1.51B

GMED:

$10.53B

EPS

TBLA:

$0.36

GMED:

$4.28

PE Ratio

TBLA:

15.26

GMED:

18.23

PEG Ratio

TBLA:

0.08

GMED:

0.19

PS Ratio

TBLA:

1.02

GMED:

3.45

PB Ratio

TBLA:

1.67

GMED:

2.28

Total Revenue (TTM)

TBLA:

$1.65B

GMED:

$3.10B

Gross Profit (TTM)

TBLA:

$579.78M

GMED:

$1.58B

EBITDA (TTM)

TBLA:

$210.19M

GMED:

$803.34M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

TBLA vs. GMED — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TBLA
TBLA Risk / Return Rank: 7676
Overall Rank
TBLA Sharpe Ratio Rank: 7777
Sharpe Ratio Rank
TBLA Sortino Ratio Rank: 8080
Sortino Ratio Rank
TBLA Omega Ratio Rank: 7777
Omega Ratio Rank
TBLA Calmar Ratio Rank: 7272
Calmar Ratio Rank
TBLA Martin Ratio Rank: 7373
Martin Ratio Rank

GMED
GMED Risk / Return Rank: 7373
Overall Rank
GMED Sharpe Ratio Rank: 6969
Sharpe Ratio Rank
GMED Sortino Ratio Rank: 7575
Sortino Ratio Rank
GMED Omega Ratio Rank: 7272
Omega Ratio Rank
GMED Calmar Ratio Rank: 7575
Calmar Ratio Rank
GMED Martin Ratio Rank: 7575
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TBLA vs. GMED - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Taboola.com Ltd. (TBLA) and Globus Medical, Inc. (GMED). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


TBLAGMEDDifference
Sharpe ratioReturn per unit of total volatility

+0.35

Sortino ratioReturn per unit of downside risk

+0.32

Omega ratioGain probability vs. loss probability

1.24

1.21

+0.03

Calmar ratioReturn relative to maximum drawdown

1.40

1.60

-0.20

Martin ratioReturn relative to average drawdown

3.29

3.87

-0.58

TBLA vs. GMED - Sharpe Ratio Comparison

The current TBLA Sharpe Ratio is 1.06, which is higher than the GMED Sharpe Ratio of 0.71. The chart below compares the historical Sharpe Ratios of TBLA and GMED, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

TBLA vs. GMED - Drawdown Comparison

The maximum TBLA drawdown since its inception was -85.51%, which is greater than GMED's maximum drawdown of -47.91%. Use the drawdown chart below to compare losses from any high point for TBLA and GMED.


Loading charts...

Drawdown Indicators


TBLAGMEDDifference

Max Drawdown

Largest peak-to-trough decline

-85.51%

-47.91%

-37.60%

Max Drawdown (1Y)

Largest decline over 1 year

-36.01%

-22.10%

-13.91%

Max Drawdown (3Y)

Largest decline over 3 years

-47.84%

-44.40%

-3.44%

Max Drawdown (5Y)

Largest decline over 5 years

-84.47%

-47.91%

-36.56%

Max Drawdown (10Y)

Largest decline over 10 years

-47.91%

Current Drawdown

Current decline from peak

-50.00%

-19.32%

-30.68%

Average Drawdown

Average peak-to-trough decline

-62.31%

-15.33%

-46.98%

Ulcer Index

Depth and duration of drawdowns from previous peaks

15.46%

9.13%

+6.33%

Volatility

TBLA vs. GMED - Volatility Comparison

Taboola.com Ltd. (TBLA) has a higher volatility of 16.69% compared to Globus Medical, Inc. (GMED) at 13.69%. This indicates that TBLA's price experiences larger fluctuations and is considered to be riskier than GMED based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


TBLAGMEDDifference

Volatility (1M)

Calculated over the trailing 1-month period

16.69%

13.69%

+3.00%

Volatility (6M)

Calculated over the trailing 6-month period

38.00%

25.33%

+12.67%

Volatility (1Y)

Calculated over the trailing 1-year period

47.32%

49.46%

-2.14%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

59.32%

38.27%

+21.05%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

59.29%

35.68%

+23.61%

Dividends

TBLA vs. GMED - Dividend Comparison

Neither TBLA nor GMED has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

TBLA vs. GMED - Financials Comparison

This section allows you to compare key financial metrics between Taboola.com Ltd. and Globus Medical, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


200.00M300.00M400.00M500.00M600.00M700.00M800.00MJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
164.02M
759.85M
(TBLA) Total Revenue
(GMED) Total Revenue
Values in USD except per share items

TBLA vs. GMED - Profitability Comparison

The chart below illustrates the profitability comparison between Taboola.com Ltd. and Globus Medical, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
79.0%
0
Portfolio components
TBLA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Taboola.com Ltd. reported a gross profit of 129.58M and revenue of 164.02M. Therefore, the gross margin over that period was 79.0%.

GMED - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Globus Medical, Inc. reported a gross profit of 0.00 and revenue of 759.85M. Therefore, the gross margin over that period was 0.0%.

TBLA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Taboola.com Ltd. reported an operating income of 69.38M and revenue of 164.02M, resulting in an operating margin of 42.3%.

GMED - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Globus Medical, Inc. reported an operating income of 150.39M and revenue of 759.85M, resulting in an operating margin of 19.8%.

TBLA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Taboola.com Ltd. reported a net income of 59.07M and revenue of 164.02M, resulting in a net margin of 36.0%.

GMED - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Globus Medical, Inc. reported a net income of 124.30M and revenue of 759.85M, resulting in a net margin of 16.4%.


Frequently Asked Questions


TBLA and GMED have a correlation of 0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

TBLA has higher volatility (16.69%) compared to GMED (13.69%). In terms of maximum drawdown, TBLA dropped -85.51% vs GMED's -47.91%.

TBLA currently has the higher Sharpe Ratio (1.06 vs 0.71), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for TBLA and GMED

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer